Table 2.
Patient’s characteristics based on vitamin D serum level
| Vit. D ≥ 30 ng/mL Group 1 | 30 > Vit. D ≥ 20 ng/mL (insufficiency) Group 2 | 20 > Vit. D ≥ 10 ng/mL (moderate deficiency) Group 3 | Vit. D < 10 ng/mL (severe deficiency) Group 4 | |
|---|---|---|---|---|
| Patients (n, %) | 8 (19) | 11 (26) | 13 (31) | 10 (24) |
| Sex (M/F) | 3/5 | 7/4 | 12/1 | 8/2 |
| Age (years, mean, SD) | 64 ± 18 | 64 ± 13 | 60 ± 6.9 | 74 ± 11 |
| BMI (mean, SD) | 27 ± 4 | 28 ± 4.10 | 31 ± 6.02 | 29 ± 4.75 |
| SOFA score (mean, SD) | 2 ± 0.74 | 3 ± 1.81 | 2 ± 1.51 | 3 ± 1.06 |
| Smoking habit | ||||
| Smokers | 0 | 0 | 2 | 0 |
| Ex-smokers | 3 | 4 | 5 | 6 |
| Never smokers | 5 | 7 | 6 | 4 |
| Patients with comorbidity | 6 | 11 | 9 | 10 |
| Patients without comorbidity | 2 | 0 | 4 | 0 |
| Comorbidity | ||||
| Hypertension | 5 | 8 | 5 | 8 |
| Cardiovascular disease | 2 | 6 | 4 | 4 |
| Chronic kidney disease | 2 | 6 | 4 | 4 |
| Diabetes type II | 2 | 4 | 3 | 2 |
| Cerebrovascular disease | 0 | 4 | 0 | 1 |
| Psycosis, depression, anxiety | 1 | 4 | 2 | 3 |
| Malignancy | 1 | 1 | 2 | 1 |
| COPD | 1 | 2 | 0 | 2 |
| Asthma | 2 | 0 | 0 | 0 |
BMI body mass index, SOFA sequential organ failure assessment, COPD chronic obstructive pulmonary disease, Vit vitamin